Dennis Sabo is the Managing Partner at Sabur Technologies, a company focusing on licensing and commercializing high potential medical device technologies. As Managing Partner, Mr. Sabo utilizes his over thirty years experience in the medical device industry to not only identify leading-edge technologies but to further coordinate the complex processes of manufacturing, regulatory and commercialization of these technologies into valuable market oriented products.
Before co-founding Sabur Technologies, Mr. Sabo was Chief Operating Officer of Serim Research Corporation. Serim Research developed, manufactured and marketed a broad range of dry phase chemistry products to the dialysis, infection control and diagnostic marketplaces.
Previously, Mr. Sabo was Senior Vice President in charge of worldwide operations for Bayer Corporation’s Near Patient Care Business Unit. The NPC Business Unit accounts for over $400 Million in revenues for Bayer Corp and concentrates in the areas of diabetes and urine chemistry plus near patient care systems for hospital laboratories.
Mr. Sabo also held various marketing and executive positions within Bayer for twenty- five years including seven years abroad.
Mr. Sabo was educated at Bowling Green State University and Johns Hopkins University.